GlobeNews Wire

Natural Remedies Advances Sleep Health Research with Holixer During National Sleep Awareness Month

BANGALORE, India, March 10, 2026 (GLOBE NEWSWIRE) -- During National Sleep Awareness Month in March, Natural Remedies is highlighting human clinical…

3 months ago

NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026

March 10, 2026 08:05 ET  | Source: NKGen Biotech, Inc. SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen…

3 months ago

API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper

ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC), a nonprofit dedicated to strengthening national health security…

3 months ago

LECTRA : Monthly declaration of the total number of shares and voting rights composing the company’s capital (at February 28th,2026)

Monthly declaration of the total number of shares and voting rights composing the company's capital (at February 28th, 2026) This…

3 months ago

Darktrace Appoints Ed Jennings as President and CEO

Veteran Leader Brings Deep Software and Cybersecurity Experience March 09, 2026 13:00 ET  | Source: Darktrace Cambridge, UK, March 09,…

3 months ago

Dstillerys Melinda Han Williams Named to ADWEEKs AI Power 50

Dstillery Chief Data Scientist recognized for AI innovation March 09, 2026 12:52 ET  | Source: Dstillery, Inc. NEW YORK, March…

3 months ago

Surgery Partners, Inc. to Present at Upcoming Investor Conference

March 09, 2026 12:04 ET  | Source: Surgery Partners, Inc. BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners,…

3 months ago

Zealand Pharma to participate in upcoming investor conferences in March 2026

March 09, 2026 12:01 ET  | Source: Zealand Pharma Press release – No. 5 / 2026 Zealand Pharma to participate…

3 months ago

CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026 March 09, 2026 10:21 ET…

3 months ago

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

March 08, 2026 14:00 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE)…

3 months ago